KEYWORD INDEX
| |
|
|
|
|
|
Search results for: "S"
Results 1 - 10 of 344 shown below |
|
S-100![]() |
|
| Kimberly Bell, David Shokrian, Carl Potenzieri and Patricia M Whitaker-Azmitia Harm Avoidance, Anxiety, and Response to Novelty in the Adolescent S-100 Transgenic Mouse: Role of Serotonin and Relevance to Down Syndromedoi:10.1038/sj.npp.1300242 Neuropsychopharmacology 28, 1840-1845 | Abstract | Full text | PDF | |
|
| S-ketamine |
|
| Euphrosyne Gouzoulis-Mayfrank, Karsten Heekeren, Anna Neukirch, Martina Stoll, Carsten Stock, Joerg Daumann, Maja Obradovic and Karl-Artur Kovar Inhibition of Return in the Human 5HT2A Agonist and NMDA Antagonist Model of Psychosis doi:10.1038/sj.npp.1300882 Neuropsychopharmacology 31, 431-441 | Abstract | Full text | PDF | |
|
| S–mephenytoin 4–hydroxylation |
|
| Koichi Otani, Norio Yasui, Sunao Kaneko, Tadashi Ohkubo, Takako Osanai, Kazunobu Sugawara, Kunihiko Hayashi, Kan Chiba and Takashi Ishizaki Effects of Genetically Determined S–Mephenytoin 4–Hydroxylation Status and Cigarette Smoking on the Single–Dose Pharmacokinetics of Oral Alprazolam doi:10.1016/S0893-133X(96)00165-0 Neuropsychopharmacology 16, 8-14 | Abstract | PDF | |
|
| S100 proteins |
|
| Matthias Rothermundt, Gerald Ponath, Thomas Glaser, Guenter Hetzel and Volker Arolt S100B Serum Levels and Long-Term Improvement of Negative Symptoms in Patients with Schizophrenia doi:10.1038/sj.npp.1300403 Neuropsychopharmacology 29, 1004-1011 | Abstract | Full text | PDF | |
|
| S[+]-N-n-propylnorapomorphine |
|
| Frank I Tarazi, Sylva K Yeghiayan, Ross J Baldessarini, Nora S Kula and John L Neumeyer Long-Term Effects of S(+)N-n-Propylnorapomorphine Compared with Typical and Atypical Antipsychotics: Differential Increases of Cerebrocortical D2-Like and Striatolimbic D4-Like Dopamine Receptors doi:10.1016/S0893-133X(97)00046-8 Neuropsychopharmacology 17, 186-196 | Abstract | PDF | |
|
| saccade |
|
| Sheree Cairney, Alan R Clough, Paul Maruff, Alex Collie, Bart J Currie and Jon Currie Saccade and Cognitive Function in Chronic Kava Users doi:10.1038/sj.npp.1300052 Neuropsychopharmacology 28, 389-396 | Abstract | Full text | PDF | |
|
| Saccades |
|
| Deborah S Cowley, Peter P Roy-Byrne, Allen Radant, James C Ritchie, David J Greenblatt, Charles B Nemeroff and Daniel W Hommer Benzodiazepine Sensitivity in Panic Disorder: Effects of Chronic Alprazolam Treatment doi:10.1016/0893-133X(94)00074-A Neuropsychopharmacology 12, 147-157 | Abstract | PDF | |
|
| John A Sweeney, Kenneth S Bauer, Matcheri S Keshavan, Gretchen L Haas, Nina R Schooler and Patricia D Kroboth Adverse Effects of Risperidone on Eye Movement Activity: A Comparison of Risperidone and Haloperidol in Antipsychotic-Naive Schizophrenic Patients doi:10.1016/S0893-133X(96)00195-9 Neuropsychopharmacology 16, 217-228 | Abstract | PDF | |
|
| Ann Olincy, Randal G Ross, David A Young, Margaret Roath and Robert Freedman Improvement in Smooth Pursuit Eye Movements after Cigarette Smoking in Schizophrenic Patients doi:10.1016/S0893-133X(97)00095-X Neuropsychopharmacology 18, 175-185 | Abstract | PDF | |
|
| Saccadic eye velocity |
|
| Inger Sundströ, Sigrid Nyberg and Torbjörn Bäckström Patients with Premenstrual Syndrome Have Reduced Sensitivity to Midazolam Compared to Control Subjects doi:10.1016/S0893-133X(97)00086-9 Neuropsychopharmacology 17, 370-381 | Abstract | PDF | |
|
| saccharin |
|
| Jennifer Lynn Short, Catherine Ledent, John Drago and Andrew John Lawrence Receptor Crosstalk: Characterization of Mice Deficient in Dopamine D1 and Adenosine A2A Receptors doi:10.1038/sj.npp.1300852 Neuropsychopharmacology 31, 525-534 | Abstract | Full text | PDF | |
|
| safety |
|
| Sheena A Josselyn, William A Falls, Jonathan C Gewirtz, Paul Pistell and Michael Davis The Nucleus Accumbens is not Critically Involved in Mediating the Effects of a Safety Signal on Behavior doi:10.1038/sj.npp.1300530 Neuropsychopharmacology 30, 17-26 | Abstract | Full text | PDF | |
|
| Result page | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | |
|
Next |
| top |
|


Transgenic Mouse: Role of Serotonin and Relevance to Down Syndrome
